PharmExec Blog
Follow Us
RSS
Bookstore
Monthly Archives: March 2008
e-Pedigree: Delay, Delay, Delay
Looks like pharma companies and wholesalers will have two more years to get the kinks worked out of their electronic pedigree system.
The California State Board of Pharmacy just announced that it would delay its e-pedigree law that would require all drugs that pass through the state to be electronically tracked. The date has been pushed [...]
Posted in Supply Chain, Technology 4 Comments
HIV Ignored?
South Park and AIDS Foundation Think So
Looks like everyone is fair game on the Comedy Central show South Park–even Big Pharma. In one of the show’s funniest and most irreverent episodes to date, Eric Cartman (the potty-mouthed chubby kid with the poof-ball hat) becomes infected with HIV during a routine tonsillectomy. And it turns out nobody cares.
Eric goes on an adventure [...]
Posted in Corporate Responsibility, Regulatory 1 Comment
Secrets of the Dealmakers Revealed . . .
I had a chance late last week to moderate a panel at the Healthcare Dealmaking Symposium, sponsored by our friends at The Deal. My panelists, Annarie Lyles, SVP and Head of Corporate Development for Genmab, and Robert Knowles, Senior Director of Worldwide Business Development for Pfizer, had some very interesting insights into the state of [...]
Posted in Deals Leave a comment
Heparin Contaminant Identified
After weeks of questions and few answers, FDA has identified the contaminant in batches of Baxter’s blood-thinner heparin as over-sulfated chondroitin sulfate, a modified version of a biologically derived compound not found in heparin.
The over-sulfated compound found in the batches is unnatural and is more than likely chemically modified, Janet Woodcock, director of FDA’s Center [...]
Posted in Manufacturing Leave a comment
ACC News Echoes Cost/Benefit Concerns